Wednesday, August 31, 2011

Botox injection onabotulinumtoxinA urinary incontinence nervous system damage

Botox can be used in treatment of urinary incontinence because of damage in nervous tissue.

Urinary incontinence is a condition where a patient’s bladder can not hold urine, it may be because of certain surgeries like removal of prostate gland or because of certain neurologic conditions like spinal chord injury or multiple sclerosis (condition which develops due to damage in nerves in brain and spinal chord).

US FDA has approved Botox (onabotulinumtoxinA) injection for treatment of urinary incontinence developed due to neurological diseases which makes urinary bladder overactive.So fare urinary incontinence was treated with catheter to remove urine from bladder and drugs which act by bringing relaxation in muscles of bladder because of bladder can store urine.

Botox injection containing onabotulinumtoxinA is injected in to bladder, which brings about relaxation of bladder muscle, so that bladder can store more urine and reduce the effect of urinary incontinence, which other wise is very difficult to manage in case if it is associated with neurological damages. Injection of Botox is done with a procedure called as cystoscopy with which doctor can see inner surface of bladder , general anesthesia may be required to carryout cystoscopy.

In urinary incontinence associated with effect of Botox on bladder muscle lasts up to ten months.
Botox has showed good improvement in a clinical study which involved 691 patients affected with urinary incontinence due to spinal chord injury or multiple sclerosis study was compared with placebo group.
US FDA has also approved Botox for treatment of chronic migraine headaches. Botox is also used to treat facial frown lines and to treat contraction and stiffness in some muscles, it is also used to treat twitching of eyelid and improper aligned eyes because of muscular contractions.

Adverse effects of Botox when used for urinary incontinence are urinary tract infection, urine retention, it is required to carryout self catheterization to empty bladder.

Botox is marketed by Allergan Inc., of Irvine, Calif USA.

You may also like

Why Betalactam Antibiotics require a separate manufacturing aria in a pharmaceutical manufacturing company?

Chemistry behind the allergic reactions and mode of action of betalactum antibiotics

US FDA approved first oral drug to reduce Multiple Sclerosis MS relapses

US FDA limits dosage of acetaminophen to 325 mg per unit dosage form,Requires boxed warning on lables.

US FDA honours woman who rejected thalidomide and saved millions of children's from thalidomide

A Pharmaceutical exceipent Beta Cyclodextrin being used in a life saving treatment

Nanoparticles of insulin in place of painful injections in treatment for diabetes patients, transdermal , nasal drug delivery systems

Corifact becomes the first drug to treat congenital deficiency of Factor XII.

Protein which is responsible for cancer spread discovered An antisense RNA treatment or a drug could be designed to treat cancer efficiently and safely.

Novel Drugs: Cancer Chemotherapy Using Nanoparticles May Reduce Harmful Side Effects.

What is Nanotechnology, its applications in medicine and pharmaceuticals, drug developments?

Pharma sales jobs Find best pharmaceutical company Job

What is Therapeutic Index ?

What is Narrow Therapeutic Range Drug?

What is High Efficiency Particulate Air( HEPA ) filter ?

What is a Laminar Air Flow Cabinet.

What is an Isolator in pharmaceutical manufacturing.?

What is 21 CFR Part 11, US FDA compliance and CFR 21 Part 11?

CFR 21 part 11 and its application on computarised systems used in clinical trials US FDA guidelines
Pharmaceutical Validation

Types of validations in pharmaceutical manufacturing

Requirements of documents for validation of sterilisation process

Clean Room Classification

Find a Job in Pharmaceutical Company -->JOBS IN PHARMA INDUSTRY<---

Quality assurance in pharma industry

Quality by design concept for pharmaceutical industry

Quality by design concept in pharmaceutical industryan explanation

No comments: